R. Königsberg

发表

Luminal A and Luminal B subtypes in patients with breast cancer 65 years of age and older.

C. Dittrich, G. Pfeiler, R. Königsberg, 2013 .

Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.

R. Greil, M. Gnant, H. Samonigg, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cell Cycle Dysregulation Influences Survival in High Risk Breast Cancer Patients

T. Thalhammer, W. Jäger, M. Santis, 2008, Cancer investigation.

Coexpression of the melatonin receptor 1 and nestin in human breast cancer specimens

T. Thalhammer, W. Jäger, M. Klimpfinger, 2009, Journal of pineal research.

Impact of AdipoR1 expression on breast cancer development.

E. Kubista, C. Singer, G. Pfeiler, 2010, Gynecologic oncology.

Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab

C. Dittrich, R. Königsberg, J. Maierhofer, 2014, Radiology and oncology.

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

R. Stauber, F. Hucke, W. Vogel, 2011, Alimentary pharmacology & therapeutics.

Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods.

R. Zeillinger, M. Hudec, C. Dittrich, 2010, Cancer letters.

Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.

R. Pirker, M. Filipits, G. Pohl, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer

M. Gnant, P. Dubsky, R. Exner, 2013, British Journal of Cancer.

Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.

H. Kittler, U. Jäger, I. Simonitsch, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance

U. Jäger, H. Kaufmann, J. Ackermann, 2000, Leukemia.

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.

H. Kaufmann, J. Ackermann, H. Gisslinger, 2000, Blood.

Deletion of 13 q 14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization

H. Kaufmann, J. Ackermann, H. Gisslinger, 2000 .

Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients

E. Kubista, M. Seifert, C. Singer, 2011, Climacteric : the journal of the International Menopause Society.

Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial.

M. D. De Santis, F. Sedlmayer, C. Dittrich, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

Giovanna Bises, Fritz Wrba, E. Obermayr, 2011, Acta oncologica.

Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial

M. Mittlböck, C. Dittrich, M. Czejka, 2018, Investigational new drugs.

Breast Cancer Subtypes in Patients Aged 70 Years and Older

C. Dittrich, G. Pfeiler, R. Königsberg, 2016, Cancer investigation.

Clinical and Economic Aspects of KRAS Mutational Status as Predictor for Epidermal Growth Factor Receptor Inhibitor Therapy in Metastatic Colorectal Cancer Patients

C. Dittrich, M. Klimpfinger, R. Königsberg, 2012, Oncology.

Melatonin receptors, melatonin metabolizing enzymes and cyclin D1 in human breast cancer

Katrin Wlcek, M. Svoboda, T. Thalhammer, 2011, Journal of receptor and signal transduction research.

Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.

Wolfgang Vogel, W. Vogel, A. Weissmann, 2009, The oncologist.

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.

R. Stauber, F. Hucke, W. Vogel, 2012, Radiology.

Prognostic Assessment and Adjuvant Treatment Strategies Within Early-Stage, Sporadic Triple Negative Breast Cancer Patients

R. Zeillinger, C. Singer, M. Hudec, 2011, Cancer investigation.

Impact of body mass index (BMI) on endocrine therapy in premenopausal breast cancer patients: An analysis of the ABCSG-12 trial.

R. Greil, M. Gnant, H. Samonigg, 2010 .

Follicle stimulating hormone (FSH) as a surrogate parameter for the effectiveness of endocrine therapy with or without zoledronic acid in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial.

R. Greil, M. Gnant, P. Dubsky, 2014 .

Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial.

R. Greil, M. Gnant, H. Samonigg, 2011, Journal of Clinical Oncology.

Impact of body mass index (BMI) on the efficacy of zoledronic acid in premenopausal patients with hormone receptor positive breast cancer: An analysis of the ABCSG-12 trial.

R. Greil, M. Gnant, H. Samonigg, 2012 .

Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patients.

R. Zeillinger, C. Singer, C. Dittrich, 2012, European journal of cancer.

Prognostic factors in patients with hepatocellular carcinoma treated with Sorafenib

R. Stauber, F. Hucke, W. Vogel, 2011 .

How transferable are recommendations of the era of treating conventionally defined breast cancer for the era of molecularly characterised breast cancer?

C. Dittrich, R. Königsberg, 2012, Gland surgery.